| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
19,652 |
18,025 |
$5.61M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
20,648 |
19,534 |
$4.38M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
8,415 |
7,685 |
$2.84M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,361 |
3,186 |
$2.06M |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,473 |
4,238 |
$1.50M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,579 |
2,419 |
$1.26M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
12,876 |
3,227 |
$1.19M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
11,497 |
10,173 |
$1.08M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
7,077 |
6,711 |
$1.07M |
| 71045 |
Radiologic examination, chest; single view |
10,367 |
9,533 |
$806K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
5,787 |
4,792 |
$747K |
| 80053 |
Comprehensive metabolic panel |
32,399 |
29,074 |
$742K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,790 |
1,703 |
$701K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
7,776 |
6,849 |
$618K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,184 |
1,115 |
$567K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,191 |
4,649 |
$407K |
| G0378 |
Hospital observation service, per hour |
895 |
805 |
$388K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,805 |
1,791 |
$376K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
8,236 |
7,365 |
$366K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,159 |
5,574 |
$350K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
6,306 |
5,871 |
$330K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,992 |
1,945 |
$275K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
30,298 |
26,806 |
$269K |
| 71250 |
|
888 |
827 |
$248K |
| 71046 |
Radiologic examination, chest; 2 views |
2,871 |
2,774 |
$238K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
624 |
603 |
$233K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,587 |
1,943 |
$225K |
| 84484 |
|
9,707 |
7,424 |
$177K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,238 |
2,142 |
$176K |
| 36415 |
Collection of venous blood by venipuncture |
37,520 |
33,059 |
$172K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
3,234 |
1,141 |
$172K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,588 |
1,523 |
$163K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,336 |
2,235 |
$157K |
| 73630 |
|
1,625 |
1,574 |
$150K |
| 81001 |
|
18,128 |
16,816 |
$146K |
| 80061 |
Lipid panel |
8,052 |
7,927 |
$141K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
981 |
960 |
$139K |
| 85379 |
|
2,960 |
2,721 |
$135K |
| 84443 |
Thyroid stimulating hormone (TSH) |
10,541 |
10,227 |
$135K |
| 73610 |
|
986 |
903 |
$129K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,082 |
1,048 |
$129K |
| 72100 |
|
911 |
892 |
$125K |
| 73030 |
|
1,068 |
1,026 |
$123K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,730 |
2,546 |
$109K |
| 84439 |
|
4,313 |
4,223 |
$106K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
4,428 |
4,346 |
$105K |
| 87040 |
|
4,801 |
2,774 |
$100K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,010 |
1,910 |
$99K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,728 |
1,532 |
$93K |
| 83605 |
|
3,851 |
3,095 |
$89K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
7,865 |
7,722 |
$87K |
| 83880 |
|
4,021 |
3,618 |
$86K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,426 |
2,324 |
$86K |
| 73562 |
|
635 |
619 |
$85K |
| 83690 |
|
7,319 |
6,720 |
$79K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,717 |
4,326 |
$76K |
| 84703 |
|
4,202 |
3,974 |
$62K |
| 76830 |
Ultrasound, transvaginal |
423 |
416 |
$60K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,064 |
2,021 |
$60K |
| 85027 |
|
7,632 |
7,371 |
$58K |
| 84702 |
|
2,504 |
2,075 |
$57K |
| 73130 |
|
554 |
532 |
$56K |
| 87081 |
|
3,011 |
2,948 |
$55K |
| 83874 |
|
1,802 |
1,655 |
$53K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,572 |
4,293 |
$49K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
463 |
450 |
$47K |
| 73560 |
|
510 |
490 |
$43K |
| 73502 |
|
506 |
428 |
$42K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
205 |
203 |
$39K |
| 76770 |
|
241 |
238 |
$36K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
239 |
233 |
$36K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
899 |
869 |
$36K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
819 |
282 |
$35K |
| 87186 |
|
1,881 |
1,557 |
$31K |
| 94761 |
|
568 |
507 |
$30K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,815 |
2,546 |
$30K |
| 74018 |
|
362 |
349 |
$28K |
| 70486 |
|
101 |
100 |
$27K |
| 73564 |
|
172 |
166 |
$26K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
1,056 |
340 |
$26K |
| 86140 |
|
2,566 |
2,364 |
$26K |
| 76536 |
|
190 |
188 |
$26K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,621 |
1,561 |
$26K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
76 |
74 |
$26K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
37 |
37 |
$25K |
| 86900 |
|
2,256 |
2,112 |
$25K |
| 86850 |
|
2,138 |
2,015 |
$25K |
| 70496 |
|
50 |
49 |
$24K |
| 73110 |
|
253 |
237 |
$24K |
| 85007 |
|
1,916 |
1,785 |
$24K |
| 85610 |
|
3,337 |
3,025 |
$24K |
| 70498 |
|
49 |
48 |
$24K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,057 |
917 |
$23K |
| 84481 |
|
1,651 |
1,633 |
$23K |
| 83735 |
|
2,310 |
2,089 |
$22K |
| 82607 |
|
1,190 |
1,169 |
$19K |
| 73590 |
|
206 |
176 |
$18K |
| 97161 |
|
423 |
407 |
$18K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,067 |
803 |
$18K |
| 82728 |
|
1,245 |
1,213 |
$18K |
| 82553 |
|
1,075 |
985 |
$17K |
| 86803 |
|
979 |
965 |
$17K |
| 87077 |
|
1,996 |
1,894 |
$17K |
| 87340 |
|
1,193 |
1,183 |
$17K |
| 86762 |
|
804 |
794 |
$16K |
| 96376 |
|
651 |
591 |
$16K |
| 85652 |
|
1,998 |
1,856 |
$16K |
| 82962 |
|
3,321 |
2,289 |
$15K |
| 84145 |
|
627 |
585 |
$15K |
| 72131 |
|
42 |
39 |
$14K |
| 73120 |
|
107 |
100 |
$14K |
| 82150 |
|
1,145 |
1,079 |
$14K |
| 86787 |
|
781 |
776 |
$14K |
| 86901 |
|
2,244 |
2,097 |
$14K |
| 85730 |
|
1,407 |
1,292 |
$14K |
| 82043 |
|
1,393 |
1,364 |
$13K |
| 87400 |
|
704 |
687 |
$13K |
| 93971 |
|
100 |
96 |
$13K |
| 83540 |
|
1,431 |
1,408 |
$13K |
| 86592 |
|
1,473 |
1,454 |
$13K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
294 |
120 |
$12K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
32 |
32 |
$12K |
| 77080 |
|
111 |
111 |
$12K |
| J2704 |
Injection, propofol, 10 mg |
1,121 |
1,043 |
$12K |
| 72040 |
|
84 |
82 |
$12K |
| 87428 |
|
146 |
137 |
$11K |
| 73090 |
|
126 |
117 |
$11K |
| 93017 |
|
60 |
58 |
$11K |
| 83550 |
|
1,056 |
1,042 |
$11K |
| 93970 |
|
65 |
63 |
$11K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
12 |
12 |
$11K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,233 |
2,777 |
$10K |
| 86703 |
|
657 |
656 |
$10K |
| 59025 |
Fetal non-stress test |
75 |
66 |
$9K |
| 85651 |
|
837 |
807 |
$8K |
| 73080 |
|
81 |
76 |
$8K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
189 |
178 |
$8K |
| 82550 |
|
1,574 |
1,434 |
$8K |
| 86780 |
|
513 |
505 |
$8K |
| 83655 |
|
414 |
411 |
$8K |
| 96367 |
|
213 |
195 |
$8K |
| 82746 |
|
576 |
560 |
$8K |
| 87807 |
|
214 |
214 |
$7K |
| 72110 |
|
61 |
61 |
$7K |
| 87650 |
|
212 |
189 |
$7K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
162 |
153 |
$7K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,140 |
2,804 |
$7K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
12 |
12 |
$6K |
| G0433 |
Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening |
341 |
337 |
$6K |
| 97035 |
|
232 |
86 |
$5K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
76 |
74 |
$5K |
| 74021 |
|
43 |
43 |
$5K |
| 76000 |
|
27 |
27 |
$5K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
12 |
12 |
$4K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
126 |
121 |
$4K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
126 |
121 |
$4K |
| 51702 |
|
43 |
40 |
$4K |
| 84153 |
|
276 |
268 |
$4K |
| 0002A |
|
72 |
72 |
$3K |
| 73552 |
|
54 |
41 |
$3K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
355 |
342 |
$3K |
| 73100 |
|
28 |
28 |
$3K |
| 82570 |
|
585 |
554 |
$3K |
| 84156 |
|
249 |
229 |
$3K |
| 84030 |
|
336 |
306 |
$3K |
| 87070 |
|
191 |
180 |
$3K |
| G0435 |
Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening |
161 |
157 |
$3K |
| 97010 |
|
440 |
143 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
118 |
108 |
$2K |
| 87205 |
|
308 |
277 |
$2K |
| 97116 |
|
74 |
29 |
$2K |
| 93925 |
|
14 |
14 |
$2K |
| 87490 |
|
69 |
69 |
$2K |
| 80076 |
|
157 |
149 |
$2K |
| 86038 |
|
129 |
123 |
$2K |
| 83013 |
|
29 |
28 |
$2K |
| 77066 |
Tomosynthesis, mammo |
13 |
13 |
$2K |
| 77065 |
Tomosynthesis, mammo |
16 |
16 |
$2K |
| 84403 |
|
93 |
92 |
$2K |
| 87420 |
|
66 |
64 |
$2K |
| 87631 |
|
12 |
12 |
$2K |
| 84100 |
|
500 |
463 |
$2K |
| 87590 |
|
69 |
69 |
$2K |
| 96368 |
|
184 |
170 |
$1K |
| 76010 |
|
13 |
13 |
$1K |
| 84402 |
|
63 |
63 |
$1K |
| 97165 |
|
25 |
24 |
$1K |
| 83001 |
|
52 |
52 |
$1K |
| 73140 |
|
13 |
12 |
$1K |
| 82803 |
|
37 |
30 |
$1K |
| 97162 |
|
17 |
15 |
$961.44 |
| 73620 |
|
16 |
13 |
$885.50 |
| 82248 |
|
133 |
110 |
$830.65 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
892 |
822 |
$827.84 |
| 0001A |
|
27 |
27 |
$783.86 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
50 |
40 |
$652.18 |
| 82270 |
|
116 |
104 |
$629.52 |
| 83002 |
|
26 |
26 |
$603.45 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
139 |
137 |
$589.24 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
595 |
511 |
$583.25 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
232 |
223 |
$567.32 |
| 94760 |
|
35 |
17 |
$552.16 |
| 82009 |
|
66 |
59 |
$540.96 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
232 |
203 |
$531.22 |
| 80074 |
|
15 |
12 |
$531.14 |
| 85045 |
|
115 |
115 |
$509.81 |
| 90715 |
|
41 |
40 |
$490.64 |
| 82140 |
|
43 |
39 |
$490.42 |
| 82670 |
|
12 |
12 |
$457.20 |
| 87075 |
|
27 |
26 |
$419.62 |
| 82247 |
|
67 |
56 |
$369.62 |
| C9113 |
Injection, pantoprazole sodium, per vial |
159 |
140 |
$336.38 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
77 |
66 |
$335.92 |
| 84450 |
|
58 |
55 |
$322.93 |
| A9270 |
Non-covered item or service |
503 |
236 |
$308.89 |
| 84550 |
|
69 |
67 |
$264.00 |
| 82951 |
|
12 |
12 |
$262.37 |
| 85384 |
|
23 |
22 |
$246.10 |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
93 |
92 |
$229.22 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
604 |
539 |
$203.41 |
| 82977 |
|
28 |
28 |
$172.74 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
214 |
196 |
$152.65 |
| 86431 |
|
12 |
12 |
$135.07 |
| 85018 |
|
27 |
27 |
$130.16 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
40 |
40 |
$127.46 |
| 87210 |
|
13 |
13 |
$126.67 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
98 |
92 |
$125.36 |
| J2060 |
Injection, lorazepam, 2 mg |
170 |
148 |
$95.16 |
| 86593 |
|
12 |
12 |
$87.24 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
87 |
81 |
$70.54 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
213 |
176 |
$59.68 |
| J1956 |
Injection, levofloxacin, 250 mg |
19 |
15 |
$49.25 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
33 |
27 |
$37.50 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
14 |
13 |
$36.35 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
54 |
52 |
$35.83 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
34 |
32 |
$23.43 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
49 |
48 |
$17.35 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
12 |
12 |
$14.47 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
109 |
99 |
$7.49 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13 |
13 |
$0.00 |